LUMOS PHARMA
Lumos Pharma, based in Austin, Texas, is an early-stage biotechnology company created to develop and commercialize a novel treatment for the rare disease Creatine Transporter Deficiency. Lumos Pharma is the exclusive licensee of technology and discoveries made in laboratories at the University of Cincinnati and has partnered with Key Opinion Leaders in the field and the United States National Institutes of Health to ensure success in developing a treatment for Creatine Transporter Deficiency. It was founded in 2014 and is headquartered in Austin, Texas.
LUMOS PHARMA
Industry:
Biopharma Biotechnology Clinical Trials Health Care Pharmaceutical
Founded:
2014-01-01
Address:
Austin, Texas, United States
Country:
United States
Website Url:
http://www.lumos-pharma.com
Total Employee:
11+
Status:
Active
Contact:
512-215-2630
Email Addresses:
[email protected]
Total Funding:
53.5 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon WordPress Content Delivery Network Google Universal Analytics
Similar Organizations
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
Immutep
Immutep is a biopharmaceutical company developing immunotherapeutics in oncology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Deerfield
Deerfield investment in Series B - Lumos Pharma
Sante Ventures
Sante Ventures investment in Series B - Lumos Pharma
Clarus Ventures
Clarus Ventures investment in Series B - Lumos Pharma
Roche Venture Fund
Roche Venture Fund investment in Series B - Lumos Pharma
Sante Ventures
Sante Ventures investment in Series A - Lumos Pharma
New Enterprise Associates
New Enterprise Associates investment in Series A - Lumos Pharma
Key Employee Changes
Official Site Inspections
http://www.lumos-pharma.com Semrush global rank: 3.85 M Semrush visits lastest month: 3.39 K
- Host name: 242.74.154.104.bc.googleusercontent.com
- IP address: 104.154.74.242
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Lumos Pharma"
Lumos Pharma Homepage
Lumos Pharma is a clinical stage, biopharmaceutical company developing therapeutics for rare diseases. Learn MoreSee details»
Lumos Company - Lumos Pharma
Lumos Pharma - Org Chart, Teams, Culture & Jobs - The Org
Lumos Pharma is a clinical-stage biopharmaceutical company whose mission is to develop new therapies for people with rare diseases, prioritizing its focus where the medical need is high, …See details»
Lumos Pharma - Crunchbase Company Profile & Funding
Lumos Pharma, based in Austin, Texas, is an early-stage biotechnology company created to develop and commercialize a novel treatment for the rare disease Creatine Transporter …See details»
Management - Lumos Pharma
Rick Hawkins is Chief Executive Officer and Chairman of Lumos Pharma. Previously, Mr. Hawkins founded Pharmaco and as Chairman, President and Chief Executive Officer, he managed the …See details»
Lumos Pharma, Inc. - AnnualReports.com
Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. The Company was founded and is led …See details»
Lumos Pharma - LinkedIn
Transforming Lives with Rare Focus | Lumos Pharma is a clinical-stage biopharmaceutical company whose mission is to develop new therapies for people with rare diseases, prioritizing …See details»
Our Team - Lumos Pharma
Our collective team experience ranges from developing novel therapeutics in-house to successful multi-party collaborations with academia and government scientists to advance innovative …See details»
Lumos Pharma - Pediatric Endocrine Society
Lumos Pharma is a clinical-stage biopharmaceutical company committed to identifying, developing, and commercializing life-changing therapies for patients and families living with rare diseases.See details»
Our Pipeline - Lumos Pharma
Lumos Pharma is a clinical-stage biopharmaceutical company committed to identifying, developing and commercializing life-changing therapies for patients and families living with rare diseases. The Company’s pipeline features …See details»
Board of Directors | Lumos Pharma
For recent transactions, including derivative transactions, see our Section 16 SEC filings page. Receive updates on the latest news from Lumos Pharma.See details»
Lumos Pharma, Inc. (LUMO) Company Profile & Overview - Stock …
2 days ago · Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of products and therapies for …See details»
Events & Presentations - Lumos Pharma
Feb 14, 2024 · Lumos Pharma, Inc. Interim Analysis & Third Quarter 2022 Earnings Conference CallSee details»
Lumos Pharma Enters into Definitive Merger Agreement with …
AUSTIN, Texas, Oct. 23, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO) (“Lumos Pharma” or the “Company”), a clinical stage biopharmaceutical company focused on …See details»
Resources - Lumos Pharma
Our science-driven organization searches out the best and most cutting-edge technologies and collaborators to help advance our projects – no matter where in the world they are advancing …See details»
Lumos Pharma Announces Positive End-of-Phase 2 Meeting with …
May 14, 2024 · Lumos Pharma, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of therapeutics for rare diseases. The Company was …See details»
Lumos Pharma Reports Full Year 2022 Financial Results, Provides ...
Dec 31, 2022 · AUSTIN, Texas, March 01, 2023 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for …See details»
News - Lumos Pharma
Lumos Pharma, Inc., a clinical stage biopharmaceutical company focused on development and commercialization of therapeutics for rare and neglected diseases, today announced that it …See details»
Lumos Pharma | LUMO Stock Price, Company Overview & News
Lumos Pharma. LUMO. $4.30-0.02 (-0.46%) Share Price. as of November 27 4:00:00 PM EST. Lumos Pharma (LUMO) Stock Price Performance. Lumos Pharma (LUMO) Stock Key Data.See details»
Financials & Filings - Lumos Pharma
Mar 7, 2023 · The Investor Relations website contains information about Lumos Pharma's business for stockholders, potential investors, and financial analysts.See details»